Das, S.; Roayapalley, P.K.; Sakagami, H.; Umemura, N.; Gorecki, D.K.J.; Hossain, M.; Kawase, M.; Das, U.; Dimmock, J.R.
Dimeric 3,5-Bis(benzylidene)-4-piperidones: Tumor-Selective Cytotoxicity and Structure-Activity Relationships. Medicines 2024, 11, 3.
https://doi.org/10.3390/medicines11010003
AMA Style
Das S, Roayapalley PK, Sakagami H, Umemura N, Gorecki DKJ, Hossain M, Kawase M, Das U, Dimmock JR.
Dimeric 3,5-Bis(benzylidene)-4-piperidones: Tumor-Selective Cytotoxicity and Structure-Activity Relationships. Medicines. 2024; 11(1):3.
https://doi.org/10.3390/medicines11010003
Chicago/Turabian Style
Das, Swagatika, Praveen K. Roayapalley, Hiroshi Sakagami, Naoki Umemura, Dennis K. J. Gorecki, Mohammad Hossain, Masami Kawase, Umashankar Das, and Jonathan R. Dimmock.
2024. "Dimeric 3,5-Bis(benzylidene)-4-piperidones: Tumor-Selective Cytotoxicity and Structure-Activity Relationships" Medicines 11, no. 1: 3.
https://doi.org/10.3390/medicines11010003
APA Style
Das, S., Roayapalley, P. K., Sakagami, H., Umemura, N., Gorecki, D. K. J., Hossain, M., Kawase, M., Das, U., & Dimmock, J. R.
(2024). Dimeric 3,5-Bis(benzylidene)-4-piperidones: Tumor-Selective Cytotoxicity and Structure-Activity Relationships. Medicines, 11(1), 3.
https://doi.org/10.3390/medicines11010003